First-Line Therapies for VTE Treatment and Secondary Prophylaxis in Patients With Cancer: A New Direction
{{output}}
Objective: To review evidence behind anticoagulants in cancer-associated venous thromboembolism (VTE) with a focus on low-molecular-weight heparins (LMWH) and the role of direct oral anticoagulants (DOACs). ... ...
